カテゴリ： MarketLine, アメリカ, 企業調査

Achillion Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4614
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Achillion Pharmaceuticals (Achillion or ‘the company’) is an American biopharmaceutical company that develops, discovers, and markets drugs for the treating infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. The company operates in the US. The company is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Achillion Pharmaceuticals, Inc.: Company Overview
Achillion Pharmaceuticals, Inc.: Overview and Key Facts
Achillion Pharmaceuticals, Inc.: Overview
Achillion Pharmaceuticals, Inc.: Key Facts
Achillion Pharmaceuticals, Inc.: Key Employees
Achillion Pharmaceuticals, Inc.: Key Employee Biographies
Achillion Pharmaceuticals, Inc.: Major Products and Services
Achillion Pharmaceuticals, Inc.: Company History
Achillion Pharmaceuticals, Inc.: Management Statement
Achillion Pharmaceuticals, Inc.: Key Competitors
Achillion Pharmaceuticals, Inc.: Company Analysis
Achillion Pharmaceuticals, Inc.: Business Description
Achillion Pharmaceuticals, Inc.: SWOT Analysis
Achillion Pharmaceuticals, Inc.: SWOT Overview
Achillion Pharmaceuticals, Inc.: Strengths
Achillion Pharmaceuticals, Inc.: Weaknesses
Achillion Pharmaceuticals, Inc.: Opportunities
Achillion Pharmaceuticals, Inc.: Threats
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Achillion Pharmaceuticals, Inc.: Financial Deals Overview
Achillion Pharmaceuticals, Inc.: Targets and Partners
Achillion Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Achillion Pharmaceuticals, Inc.: Advisors
Achillion Pharmaceuticals, Inc.: Top Legal Advisors
Achillion Pharmaceuticals, Inc.: Top Financial Advisors
Achillion Pharmaceuticals, Inc.: Capital Raising
Achillion Pharmaceuticals, Inc.: Private Equity and Ownership
Achillion Pharmaceuticals, Inc.: Recent Developments
Achillion Pharmaceuticals, Inc.: News and Events Summary
Achillion Pharmaceuticals, Inc.: Business Expansion
Achillion Pharmaceuticals, Inc.: Corporate Governance
Achillion Pharmaceuticals, Inc.: Financial Performance
Achillion Pharmaceuticals, Inc.: Market Developments
Achillion Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 3: Achillion Pharmaceuticals, Inc.: Company History
Table 4: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 5: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 14: Achillion Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 15: Achillion Pharmaceuticals, Inc.: News and Events Summary
Table 16: Achillion Pharmaceuticals, Inc.: Business Expansion
Table 17: Achillion Pharmaceuticals, Inc.: Corporate Governance
Table 18: Achillion Pharmaceuticals, Inc.: Financial Performance
Table 19: Achillion Pharmaceuticals, Inc.: Market Developments
Table 20: Achillion Pharmaceuticals, Inc.: Research & Development

★海外企業調査レポート[Achillion Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Endo International Plc (ENDP)-製薬・医療分野：企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • CloudFlare Inc (NET)：企業の財務・戦略的SWOT分析
    CloudFlare Inc (NET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Japan Post Holdings Co., Ltd.：企業の戦略・SWOT・財務分析
    Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Post Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Pascal Biosciences Inc (PAS)-製薬・医療分野：企業M&A・提携分析
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve …
  • HCA Healthcare Inc (HCA)-製薬・医療分野：企業M&A・提携分析
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • Trek 2000 International Ltd. (5AB)：企業の財務・戦略的SWOT分析
    Trek 2000 International Ltd. (5AB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Xeltis AG：企業の製品パイプライン分析2018
    Summary Xeltis AG (Xeltis) is a clinical-stage medical equipment company that harnesses advances in science to improve the treatment of heart valve related conditions. The company’s polymer-based technology platform, RestoreX, facilitates the natural restoration of heart valve through a process refe …
  • Forrester Research, Inc.：企業の戦略・SWOT・財務情報
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Gezhouba Group Co Ltd (600068)：企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Chugoku Electric Power Co., Inc.：企業の戦略・SWOT・財務分析
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Etex Group Sa：企業の戦略・SWOT・財務分析
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BYD Co Ltd (1211)：企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • New Carolin Gold Corp：企業の戦略・SWOT・財務分析
    New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report Summary New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Transport for London：企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • UbiQ Bio BV：製薬・医療：M&Aディール及び事業提携情報
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • The Kansai Electric Power Co Inc (9503)：電力：M&Aディール及び事業提携情報
    Summary The Kansai Electric Power Co Inc (KEPCo) is an integrated power utility. It produces and supplies electricity and thermal energy; and procures and sells natural gas. The company generates electricity using natural gas, nuclear, coal, oil, wind, hydro, and solar sources. Through long, medium, …
  • Bashneft (BANE)：企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • gel-e Inc：製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Freudenberg & Co KG：企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Teradata Corp (TDC)：企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆